A research team from the University of California (UC), Irvine, has revealed a previously unknown mechanism that triggers an inflammatory immune response in cells when their DNA is damaged. The ...

Interferon gamma-1b is under clinical development by Amgen and currently in Phase II for Relapsed Acute Myeloid Leukemia.

IgG MoDE Degraders: BHV-1300 Phase 1 completing last remaining dose cohorts with the optimized subcutaneous formulation with expected completion in 1H 2025. BHV-1310 first-in-human study anticipated ...

T he way people with disabilities are treated is backsliding in the U.S., advocates say. Cruel names are slung around without ...

*The actual case names have been changed for client confidentiality. Settlement amounts are all inclusive amounts (inclusive ...

Telephone 0081 43 222 7171 ext 5414; fax 0081 43 226 2160; email.morim{at}olive.ocn.ne.jp IgG anti-GQ1b antibody was present in a patient with acute ataxia and areflexia without ophthalmoplegia or ...

Newer evidence has suggested, however, that gabapentin may not work for all pain conditions and is associated with falls. As ...

Limb Ataxia 0 = Absent 1 = Present in 1 limb 2 ... Goal of the diagnostic work-up in the acute phase involves avoiding tPA-related complications and in the post-acute phase is directed at ...

Interferon gamma-1b is under clinical development by Amgen and currently in Phase II for Myelodysplastic Syndrome.

The CSF is usually normal (as in early AIDP and botulism). Ataxia and areflexia can precede paralysis by several days. Unlike Guillain-Barré, sensory symptoms tend to be minimal with tick paralysis.

Discovering another genetic disease in the Quarter Horse Research behind a recessive genetic disease found in Quarter Horses ...

On the third day, drugmakers provided updates on precision medicines for cancer and Alzheimer's, and Grail talked about the launch of a new version of the Galleri test.